1. Home
  2. IOR vs MGX Comparison

IOR vs MGX Comparison

Compare IOR & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOR
  • MGX
  • Stock Information
  • Founded
  • IOR 1984
  • MGX 2018
  • Country
  • IOR United States
  • MGX United States
  • Employees
  • IOR N/A
  • MGX N/A
  • Industry
  • IOR Real Estate Investment Trusts
  • MGX
  • Sector
  • IOR Real Estate
  • MGX
  • Exchange
  • IOR Nasdaq
  • MGX NYSE
  • Market Cap
  • IOR 75.2M
  • MGX 62.1M
  • IPO Year
  • IOR N/A
  • MGX 2024
  • Fundamental
  • Price
  • IOR $18.95
  • MGX $1.57
  • Analyst Decision
  • IOR
  • MGX Strong Buy
  • Analyst Count
  • IOR 0
  • MGX 4
  • Target Price
  • IOR N/A
  • MGX $13.00
  • AVG Volume (30 Days)
  • IOR 392.0
  • MGX 665.7K
  • Earning Date
  • IOR 08-07-2025
  • MGX 08-13-2025
  • Dividend Yield
  • IOR N/A
  • MGX N/A
  • EPS Growth
  • IOR N/A
  • MGX N/A
  • EPS
  • IOR 1.10
  • MGX N/A
  • Revenue
  • IOR N/A
  • MGX $45,263,000.00
  • Revenue This Year
  • IOR N/A
  • MGX N/A
  • Revenue Next Year
  • IOR N/A
  • MGX $11.75
  • P/E Ratio
  • IOR $17.24
  • MGX N/A
  • Revenue Growth
  • IOR N/A
  • MGX N/A
  • 52 Week Low
  • IOR $15.69
  • MGX $1.23
  • 52 Week High
  • IOR $19.30
  • MGX $5.50
  • Technical
  • Relative Strength Index (RSI)
  • IOR 69.96
  • MGX 51.41
  • Support Level
  • IOR $17.95
  • MGX $1.45
  • Resistance Level
  • IOR $19.30
  • MGX $1.66
  • Average True Range (ATR)
  • IOR 0.06
  • MGX 0.12
  • MACD
  • IOR 0.05
  • MGX 0.01
  • Stochastic Oscillator
  • IOR 70.83
  • MGX 66.67

About IOR Income Opportunity Realty Investors Inc.

Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. The business of the company is managed by Pillar Income Asset Management, Inc. The company's activities include locating, evaluating and recommending investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

Share on Social Networks: